ATE235250T1 - Inhibinzusammensetzungen und verfahren zur erhöhung der reproduzierenden leistung - Google Patents

Inhibinzusammensetzungen und verfahren zur erhöhung der reproduzierenden leistung

Info

Publication number
ATE235250T1
ATE235250T1 AT96918234T AT96918234T ATE235250T1 AT E235250 T1 ATE235250 T1 AT E235250T1 AT 96918234 T AT96918234 T AT 96918234T AT 96918234 T AT96918234 T AT 96918234T AT E235250 T1 ATE235250 T1 AT E235250T1
Authority
AT
Austria
Prior art keywords
protein
methods
inhibine
compositions
heterologous protein
Prior art date
Application number
AT96918234T
Other languages
English (en)
Inventor
William C Fioretti
Konstantin Kousoulas
Daniel G Satterlee
Original Assignee
Agritech Technologies Ltd
Univ Louisiana State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agritech Technologies Ltd, Univ Louisiana State filed Critical Agritech Technologies Ltd
Application granted granted Critical
Publication of ATE235250T1 publication Critical patent/ATE235250T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/30—Bird
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96918234T 1995-06-07 1996-06-06 Inhibinzusammensetzungen und verfahren zur erhöhung der reproduzierenden leistung ATE235250T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/481,633 US5725858A (en) 1994-02-28 1995-06-07 Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein
PCT/US1996/009229 WO1996040219A1 (en) 1995-06-07 1996-06-06 Inhibin compositions and methods of enhancing production performance

Publications (1)

Publication Number Publication Date
ATE235250T1 true ATE235250T1 (de) 2003-04-15

Family

ID=23912759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918234T ATE235250T1 (de) 1995-06-07 1996-06-06 Inhibinzusammensetzungen und verfahren zur erhöhung der reproduzierenden leistung

Country Status (13)

Country Link
US (2) US5725858A (de)
EP (1) EP0833658B1 (de)
JP (1) JPH11511964A (de)
KR (1) KR19990022555A (de)
CN (1) CN1192692A (de)
AT (1) ATE235250T1 (de)
AU (1) AU726321B2 (de)
BR (1) BR9609067A (de)
CA (1) CA2222947A1 (de)
DE (1) DE69626980D1 (de)
NZ (1) NZ310195A (de)
PL (1) PL323865A1 (de)
WO (1) WO1996040219A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030171283A1 (en) * 1994-02-28 2003-09-11 Satterlee Daniel G. Inhibin compositions and methods of enhancing production performance
AU6046198A (en) * 1997-01-31 1998-08-25 Kenneth Hoyt Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines
US5990085A (en) * 1998-05-04 1999-11-23 Michigan State University Inhibin-HBc fusion protein
US6196965B1 (en) 1998-05-21 2001-03-06 Cryofacets, Inc. Compositions methods and devices for embryo implantation for in vitro fertilization
IL126874A0 (en) * 1998-11-03 1999-09-22 Federman & Sons Holdings Ltd A new composition and method for increasing production yield of mammalian species
JP2002537776A (ja) 1999-02-25 2002-11-12 オークランド ユニサーヴィスィズ リミテッド 早発性卵巣機能不全の診断及び治療
US6303132B1 (en) 1999-07-16 2001-10-16 Ardell H. Nelson Administering progesterone using EMU oil
US6093421A (en) 1999-08-31 2000-07-25 Biotics Research Corporation Maca and antler for augmenting testosterone levels
AU2003297254A1 (en) * 2002-11-07 2004-06-03 Agritech Technology, Ltd Novel compositions that enhance production performance in avians
EP1620327B1 (de) * 2003-05-02 2007-02-28 Almar Packaging International Inc. Zwischenschüttgutbehälter
US20060234274A1 (en) * 2005-03-29 2006-10-19 Auckland Uniservices Limited Methods of diagnosis
AU2006285850A1 (en) 2005-08-29 2007-03-08 Japan Science And Technology Agency Antibody produced using ostrich and method for production thereof
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN110408623B (zh) * 2019-07-08 2021-08-31 扬州大学 一种提高鹅产蛋性能的方法
CN111183957A (zh) * 2020-02-19 2020-05-22 中国医科大学附属第一医院 一种减轻自身免疫甲状腺炎模型的构建方法及其应用
CN116375844B (zh) * 2023-02-22 2024-03-29 四川农业大学 一种抑制素抗原肽及其疫苗和制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
DE69527439T2 (de) * 1994-02-28 2003-02-20 Agritech Technologies, Ltd. Inhibin enthaltende Zusammensetzung und ihre Verwendung

Also Published As

Publication number Publication date
WO1996040219A1 (en) 1996-12-19
CN1192692A (zh) 1998-09-09
BR9609067A (pt) 2002-07-16
US5747659A (en) 1998-05-05
US5725858A (en) 1998-03-10
MX9709579A (es) 1998-10-31
NZ310195A (en) 2000-01-28
PL323865A1 (en) 1998-04-27
KR19990022555A (ko) 1999-03-25
EP0833658A1 (de) 1998-04-08
EP0833658B1 (de) 2003-03-26
JPH11511964A (ja) 1999-10-19
AU726321B2 (en) 2000-11-02
AU6094196A (en) 1996-12-30
CA2222947A1 (en) 1996-12-19
DE69626980D1 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
ATE235250T1 (de) Inhibinzusammensetzungen und verfahren zur erhöhung der reproduzierenden leistung
DE58902737D1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
BR9809656A (pt) Composição imunopotencializante
PT822199E (pt) Polipeptidos monopegilados no terminal-n e metodo para a sua preparacao
DE59301222D1 (de) Verfahren zur herstellung von organopolysiloxanharz
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
ATE404587T1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
IT8119760A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
ATE73350T1 (de) Verfahren zur tierischen wachstumsfoerderung.
FI963325A0 (fi) Inhibiinikoostumukset ja menetelmät niiden käyttämiseksi
DK1095141T3 (da) Fremgangsmåde til fremstilling af et peptid med pI-værdi over 8 eller under 5
ATE114300T1 (de) Verfahren zur herstellung von albuterol, sowie von arylglyoxal-, acetal-, hemiacetal- und hydrat-zwischenprodukten.
ATE141283T1 (de) Verfahren zur reinigung eines hochglykosylierten proteins
DE3268160D1 (en) Medicaments based on algae, and formulations thereof
ATE152722T1 (de) Verfahren zur herstellung von 9-(2-hydroxy)- ethoxy-guanin
DK0464132T3 (da) Dekorationsmiddel og fremgangsmåde til dets fremstilling
DE3482971D1 (de) Landwirtschaftliche zusammensetzungen, verfahren zur herstellung von landwirtschaftlichen zusammensetzungen und verfahren zur verwendung von landwirtschaftlichen zusammensetzungen.
ATE207139T1 (de) Verfahren zur herstellung von butantetracarbonsäure
ATE216778T1 (de) Verfahren zur herstellung von konjugaten aus einem spezifischen bindungspartner und einem kohlenhydrathaltigen protein
DE68917379D1 (de) Verfahren zur Herstellung von Proteinen, die ähnlich dem natürlich-menschlichen Apolipoprotein-E sind.
DE3887019D1 (de) Verfahren zur herstellung von zusammensetzungen mit anti-magengeschwür-wirkung.
EP0014995A3 (de) Immunisierungsmittel, Verfahren zu seiner Herstellung und seine Verwendung bei der Herstellung von Antiseren
DE59106330D1 (de) Verfahren zur herstellung von formyltetrahydropyranen.
IL72986A0 (en) Homogenous immune interferon fragment,its manufacture and pharmaceutical compositions containing it
DE68902379D1 (de) Verfahren zur herstellung von verbessertem proteinhydrolysat.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties